MWNA
MEDP icon

Marshall Wace North America’s Medpace MEDP Stock Holding History

Marshall Wace North America’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-2,142
Closed -$180K – 1468
2019
Q3 		$180K Sell
2,142
-5,700
-73% -$431K ﹤0.01% 975
2019
Q2 		$513K Buy
7,842
+2,393
+44% +$138K ﹤0.01% 884
2019
Q1 		$321K Buy
5,449
+4,716
+643% +$282K ﹤0.01% 889
2018
Q4 		$39K Buy
+733
New +$40.2K ﹤0.01% 1311
2018
Q3 		– Sell
-42,994
Closed -$1.85M – 1188
2018
Q2 		$1.85M Sell
42,994
-30,237
-41% -$1.22M 0.01% 785
2018
Q1 		$2.56M Sell
73,231
-136,077
-65% -$4.97M 0.01% 746
2017
Q4 		$7.59M Buy
+209,308
New +$7.34M 0.04% 458

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
PG
Pendal Group Sydney, Australia $11.6B AUM 12.87% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return

Marshall Wace North America's MEDP Position: Q4 2019 in Review

Marshall Wace North America sold out of Medpace (MEDP) in Q4 2019, closing a stake of 2,142 shares — an estimated $180K sold.

Marshall Wace North America first reported a position in MEDP in Q4 2017 and held it in 7 quarters. The position peaked at $7.59M in Q4 2017. 250 funds tracked by Wall St. Rank hold MEDP as of Q4 2019.

  • Marshall Wace North America reported no remaining Medpace position as of Q4 2019 after selling out during the quarter.
  • Marshall Wace North America sold 2,142 Medpace shares in Q4 2019, an estimated $180K.
  • Marshall Wace North America first reported a position in Medpace in Q4 2017 and held it in 7 quarters.
  • Marshall Wace North America's Medpace position peaked at $7.59M in Q4 2017.
  • 250 funds tracked by Wall St. Rank held Medpace as of Q4 2019.

Based on Marshall Wace North America's 13F filing for Q4 2019, filed 14 Feb 2020.